Drug intelligence / Profile preview

polyethylene glycol + simethicone

Development stage
Unknown
Lead developer
Ipsen
Modality
Small Molecules
Administration
Oral
01

Overview

Polyethylene glycol (PEG) + simethicone is a combination therapy used for bowel cleansing prior to gastrointestinal procedures such as colonoscopy and capsule endoscopy. Polyethylene glycol acts as an osmotic laxative, inducing a watery diarrhea that clears the colon of fecal matter. Simethicone is a non-absorbable surfactant that acts as an antifoaming agent by reducing the surface tension of gas bubbles in the digestive tract. This reduction in bubbles improves mucosal visualization, particularly in the right colon, and may reduce patient symptoms like bloating and abdominal discomfort. Clinical trials have demonstrated that the addition of simethicone to standard PEG regimens (ranging from 2L to 4L) significantly improves bubble scores and mucosal visibility without compromising the safety or tolerability of the preparation.

Other names
PEG + simethiconepolyethylene glycol plus simethiconePEG-ELS + simethicone
02

Targets

Gas bubbles / gas–liquid interface in the GI lumen

Beyond the preview

Go deeper on polyethylene glycol + simethicone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polyethylene glycol + simethicone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call